This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Reasons to Bet on High Beta ETFs & Stocks
by Sweta Killa
The momentum was driven by a vaccine development, which is being viewed as "a beginning to the end" of the coronavirus pandemic, and the prospect of divided congress, which is considered favorable for the economy.
Natural Gas, Silver & 3 Other Wining ETF Areas of Last Week
by Sanghamitra Saha
Wall Street was in the green zone last week with a few ETF areas offering at least a 9% return.
ETF Areas Likely to Gain on Stimulus Executive Order of Trump
by Sanghamitra Saha
On Aug 8, President Donald Trump tried to impose executive power by signing four actions on coronavirus relief.
Are Small-Cap Value ETFs Good Picks Now?
by Sanghamitra Saha
Fed and government support as well as pent-up consumer demand may boost small-cap value ETFs amid rising coronavirus cases.
High-Beta ETFs & Stocks to Tap the Soaring Stock Market
by Sweta Killa
While every corner of the market is enjoying this ascent, high-beta ETFs and stocks seem a perfect bet at present.
Are Small-Cap ETFs in Trouble?
by Sweta Killa
More pain seems to be in store for small-cap stocks than their large-cap peers, given that the pandemic has hurt the domestic economy. The latest bouts of data paint a gloomy picture of the economy for the near term.
Hit and Flop ETF Zones of Last Week
by Sweta Killa
We have highlighted ETFs from the best and worst zones of last week that could continue the same way this week as well if fundamentals remain the same.
Zacks Value Trader Highlights: RVT, FEVAX, VBR, RZV and VIOV
by Zacks Equity Research
Zacks Value Trader Highlights: RVT, FEVAX, VBR, RZV and VIOV
Should Value Investors Buy Mutual Funds?
by Tracey Ryniec
Investors have been pouring money into ETFs for years, but actively managed mutual funds could be another option for value investors.
The Zacks Analyst Blog Highlights: SPHB, RFV, RZV, ENTR and VFVA
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SPHB, RFV, RZV, ENTR and VFVA
5 High-Beta ETFs & Stocks for a Record Market
by Sweta Killa
While every corner of the market is enjoying the current ascent, high-beta ETFs and stocks seem a perfect bet at present.
Value ETFs Trumping Momentum ETFs: Here's Why
by Sanghamitra Saha
Why value ETFs have been on a tear in the past month despite a stellar Wall Street rally.
Top ETF Areas of September
by Sanghamitra Saha
Despite moderate broader market performance, these ETF areas outperformed the market in September.
Small Caps Win in September: 5 Best ETFs & Stocks
by Sweta Killa
We highlight five small-cap ETFs and stocks that have outperformed in September. These could be excellent plays for investors should the same trends prevail.
How to Play Stock Rotation With Value ETFs
by Sweta Killa
Investors seeking to participate in this market transformation could consider the ETFs that gained most over the past week.
Small-Cap Value ETFs Rallying Hard: Here's Why
by Sanghamitra Saha
Small-cap value ETFs are riding high of late on the back of a dovish Fed, heightened trade war tensions, global growth worries, geopolitical risks, stronger dollar but a decently growing U.s. economy.
5 High Beta ETFs, Stocks to Ride on Surging Market
by Sweta Killa
While every corner of the market is enjoying this ascent, high-beta ETFs and stocks seem a perfect bet at present.
Consumer Discretionary & Small-Cap: 2 ETFs to Watch on Outsized Volume
by Sweta Killa
PEZ and RZV saw massive trading volumes in last session.
The Zacks Analyst Blog Highlights: Guggenheim S&P SmallCap 600 Pure Value ETF, Guggenheim S&P MidCap 400 Pure Value ETF, Bill Barrett, AK Steel Holdings and Huntsman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Guggenheim S&P SmallCap 600 Pure Value ETF, Guggenheim S&P MidCap 400 Pure Value ETF, Bill Barrett, AK Steel Holdings and Huntsman
Small Cap ETFs Surge as House Passes Tax Bill
by Sweta Killa
House Republicans approved the biggest U.S. tax overhaul leading to a rally in the broad stock market with small caps leading the way higher.
Forget Biotechs: These Value ETFs Soared
by Tracey Ryniec
You might be surprised by what was the top performing ETF during the bull market.
The Zacks Analyst Blog Highlights: Guggenheim S&P 500 Pure Value ETF, Guggenheim S&P SmallCap 600 PureValue ETF, PowerShares NASDAQ Internet ETF, First Trust Dow Jones Internet ETF and SPDR S&P 500 ETF
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Guggenheim S&P 500 Pure Value ETF, Guggenheim S&P SmallCap 600 PureValue ETF, PowerShares NASDAQ Internet ETF, First Trust Dow Jones Internet ETF and SPDR S&P 500 ETF
The Zacks Analyst Blog Highlights: Guggenheim S&P SmallCap 600 Pure Value, Oppenheimer Small Cap Revenue, PowerShares S&P 500 High Beta Portfolio, Guggenheim S&P 500 Pure Value and Vanguard Russell 2000 Growth Index
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Guggenheim S&P SmallCap 600 Pure Value, Oppenheimer Small Cap Revenue, PowerShares S&P 500 High Beta Portfolio, Guggenheim S&P 500 Pure Value and Vanguard Russell 2000 Growth Index
The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials Fund, Guggenheim S&P SmallCap 600 Pure Value ETF, PowerShares S&P SmallCap Materials Fund, Health Insurance Innovations and Airgain
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials Fund, Guggenheim S&P SmallCap 600 Pure Value ETF, PowerShares S&P SmallCap Materials Fund, Health Insurance Innovations and Airgain
Zacks Value Investor Highlights: Vanguard Small Cap Value ETF, Guggenheim S&P Small Cap 600 Pure Value ETF, Vanguard Mid-Cap Value ETF, iShares S&P Mid Cap 400 Value ETF and Vanguard Large Cap ETF
by Zacks Equity Research
Zacks Value Investor Highlights: Vanguard Small Cap Value ETF, Guggenheim S&P Small Cap 600 Pure Value ETF, Vanguard Mid-Cap Value ETF, iShares S&P Mid Cap 400 Value ETF and Vanguard Large Cap ETF